Press Releases May 12, 2026 04:05 PM

CNB Financial Corporation Announces Quarterly Dividend For Common Stock

CNB Financial Corporation Declares Quarterly Dividend of $0.19 Per Share

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
CCNE

CNB Financial Corporation announced a quarterly cash dividend of $0.19 per share payable on June 15, 2026, to shareholders of record as of June 1, 2026. The company operates primarily through its subsidiary CNB Bank, which offers comprehensive banking services across multiple states including Pennsylvania, Ohio, New York, and Virginia.

CNB Financial Corporation Announces Quarterly Dividend For Common Stock
CCNE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Quarterly dividend declared at $0.19 per share, signaling steady returns for shareholders.
  • CNB Financial Corporation has consolidated assets of approximately $8.5 billion, indicating a solid financial position.
  • The bank operates through multiple divisions and serves a broad geographic area, including full-service banking and specialized divisions like Impressia Bank focusing on women.
  • The announcement indicates stable financial management but does not include growth or strategic changes impacting earnings significantly.

CLEARFIELD, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of CNB Financial Corporation (Nasdaq: CCNE) declared a quarterly cash dividend of $0.19 per share of common stock payable on June 15, 2026 to common stock shareholders of record as of June 1, 2026.

CNB Financial Corporation is a financial holding company with consolidated assets of approximately $8.5 billion. CNB Financial Corporation conducts business primarily through its principal subsidiary, CNB Bank. CNB Bank is a full-service bank engaging in a full range of banking activities and services, including trust and wealth management services, for individual, business, governmental, and institutional customers. CNB Bank operations include a private banking division, and 79 offices comprised of one loan production office, one mobile office, two limited service offices, and 75 full-service offices in Pennsylvania, Ohio, New York, and Virginia. CNB Bank, headquartered in Clearfield, Pennsylvania, with offices in Central and North Central Pennsylvania, serves as the multi-brand parent to various divisions. These divisions include ERIEBANK, based in Erie, Pennsylvania, with offices in Northwest Pennsylvania and Northeast Ohio; FCBank, based in Columbus, Ohio, with offices in Central Ohio; BankOnBuffalo, based in Buffalo, New York, with offices in Western New York; Ridge View Bank, based in Roanoke, Virginia, with offices in the Southwest Virginia region; ESSA Bank, based in Stroudsburg, Pennsylvania, with offices in Northeast Pennsylvania, including the Lehigh Valley region; and Impressia Bank, a division focused on banking opportunities for women, which operates in CNB Bank’s primary market areas. Additional information about CNB Financial Corporation may be found at www.CNBBank.bank.


Risks

  • Dividend payments depend on continuing strong financial performance and regulatory approvals which can vary with economic conditions.
  • Regional banking exposure could be susceptible to local economic downturns in Pennsylvania, Ohio, New York, and Virginia.
  • Competition within full-service banking and wealth management sectors may impact future profitability and market share.

More from Press Releases

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress Jun 14, 2026 Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 Jun 14, 2026 Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026 Jun 14, 2026 Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control Jun 14, 2026 Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026